Yevgeniy Semenov, MD, MA


Clinicn Investigator, Asst Prf
Dermatology, Mass General Research Institute
Assistant Professor of Dermatology
Harvard Medical School
Assistant In Dermatology
Massachusetts General Hospital
MD 2015
cancer immunotherapy; high risk skin cancer; melanoma; skin cancer

Dr. Semenov’s clinical expertise includes cutaneous oncology with a focus on melanoma and supportive oncodermatology. His research interests include epidemiology of melanoma and non-melanoma skin cancer with an emphasis on improving outcomes and treatment selection for patients with advanced disease. As part of this clinical and research focus, Dr. Semenov provides care to patients experiencing skin side effects from chemotherapy and immunotherapy used for the management of advanced cancers.

He has published more than 120 papers in leading dermatologic and oncologic publications, including the Journal of the American Academy of Dermatology, Journal of the American Medical Association Dermatology, Journal of Investigative Dermatology, British Journal of Dermatology, Journal for Immunotherapy of Cancer, and the Journal of the National Cancer Institute. His research has established robust multi-institutional and population-level evidence on the epidemiology, treatment options, and downstream outcomes for cutaneous immunotherapy toxicities.

Dr. Semenov is fluent in English and Russian. Dr. Semenov sees patients in our Boston location and at the MGH Cancer Center.